Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeDune Medical Expands Leadership Team in Atlanta, Naming Skip Ashmore as CCO...

Dune Medical Expands Leadership Team in Atlanta, Naming Skip Ashmore as CCO and Susan Turner as VP Healthcare Economics & Reimbursement

October 18, 20017

Dune Medical Devices has appointed Skip Ashmore as Chief Commercial Officer. Ashmore joins Dune with 25 years of experience in the medical device industry including engagements with Covidien, CryoLife, Baxter Healthcare and Motus GI.

Lori Chmura, Dune Medical CEO notes, “Having worked with Skip at Covidien, I have seen first-hand his ability to integrate his background in the sciences with a market driven, customer focus to the business.  Chmura said, “His expertise enhances our team’s ability to execute against our commercial strategy, pursue reimbursement and develop our next generation products. Skip’s addition to the leadership team is the next step in building a world class medical device company.”

MarginProbe, Dune Medical’s first commercial product based on its proprietary Radiofrequency (RF) Spectroscopy technology, has been helping surgeons ensure clean margins in lumpectomy procedures since 2013. Multiple peer-reviewed studies have demonstrated MarginProbe’s ability to reduce re-excision rates in women undergoing breast conserving surgery by up to 79 percent.

“Realizing that 1 in 4 women undergoing breast conserving surgery must have a repeat surgery to remove undetected cancer was a top reason to join the Dune Medical team,” says Ashmore. “Achieving standard of care status in margin detection to improve outcomes and reduce costs is a compelling mission that I am honored to lead.”

Dune’s next product earned a €3 million grant from the EC 2020 Horizon program in 2016. It will expand the company’s surgical oncology portfolio to include a soft tissue biopsy system with its first indication in breast tissue.

“Longer term, we believe our RF Spectroscopy platform can improve clinical outcomes and reduce the total cost of care across multiple cancers,” Ashmore says.

Dune has also appointed Susan Turner as V.P. Healthcare Economics and Reimbursement. Turner joins Dune with 19 years of experience in the medical device industry where she was responsible for Payer Relations and Managed Care with Hologic, Cytyc and Proxima Therapeutics.

“As the healthcare system seeks ways to improve quality and reduce spending, MarginProbe brings a necessary benefit to the delivery of care in women with breast cancer,” says Turner. “By reducing costly repeat surgeries, Dune’s technology helps advance the move from volume-based to value-based healthcare. It is important that payers recognize the value Radiofrequency Spectroscopy offers by supporting coding, payment and coverage decisions to improve access to this technology,” Turner concluded.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy